Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

1426

Actual shortage: 205 (14%)
Anticipated shortage: 0 (0%)
Avoided shortage: 1 (0%)
Resolved: 1220 (86%)

Discontinuation Reports

231

To be discontinued: 3 (1%)
Discontinued: 228 (99%)
Reversed: 0 (0%)

Late reports

235 (14%)

Overdue reports

6 (3%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
FENTORA 800MCG TABLET (EFFERVESCENT) Resolved 2019-08-22 2019-10-04 92143
FENTORA 100MCG TABLET (EFFERVESCENT) Resolved 2020-11-19 2021-02-05 128600
FENTORA 200MCG TABLET (EFFERVESCENT) Resolved 2021-01-28 2021-02-05 132630
FENTORA 600MCG TABLET (EFFERVESCENT) Resolved 2021-03-04 2021-03-18 135114
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2017-08-01 2018-05-11 17844
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2019-09-26 2019-10-04 94825
TEVA-DICLOFENAC EC 25MG TABLET (ENTERIC-COATED) Avoided shortage 2019-11-21 2020-07-10 99453
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2020-03-26 2020-05-08 109583
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2020-09-24 2020-10-22 124986
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-01-28 2021-04-08 132672
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-10 1748
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-11 1760
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2018-02-21 1769
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-10 1778
ACT OXYCODONE CR 5MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-17 2017-09-19 3366
ACT OXYCODONE CR 10MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-17 2017-09-19 3377
ACT OXYCODONE CR 20MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-17 2017-07-01 3381
ACT OXYCODONE CR 80MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-17 2017-09-19 3384
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2017-04-03 2018-02-21 5223
ACT OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Resolved 2017-05-24 2017-09-19 10978

Showing 1341 to 1360 of 1426

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64544
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64547
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64550
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64553
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623

Showing 1 to 20 of 231